MicroRNA expressions in HPV-induced cervical dysplasia and cancer

Anticancer Research

Volumn 35, Issue 1, 2015, Pages 523-530

  Gocze, Katalin ^a   Gombos, Katalin ^a   Kovacs, Krisztina ^a   Juhasz, Krisztina ^a   Gocze, Peter ^a   Kiss, Istvan ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; MicroRNA expression; Single and multiple HPV infection

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 196A; MICRORNA 203; MICRORNA 21; MICRORNA 27A; MICRORNA 34A; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FORMALIN FIXED PARAFFIN EMBEDDING; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SMOKING; SOCIAL ASPECT; TISSUE SECTION; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS STRAIN; WART VIRUS; ADOLESCENT; ADULT; AGED; GENETICS; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA; UPREGULATION; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; HUMANS; MICRORNAS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UP-REGULATION; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84920381767     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61 (2): 69-90, 2011.
2. zur Hausen H: Condylomata acuminata and human genital cancer. Cancer Res 36 (2 pt 2): 794, 1976.
3. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ and Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med 348 (6): 518-527, 2003.
4. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL and Franco EL: Human papilloma virus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15 (7): 1274-1280, 2006.
5. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N and Bosch FX; Retrospective International Survey and HPV Time TrendsStudy Group: Human papilloma virus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11 (11): 1048-1056, 2011.
6. Franco EL: A new generation of studies in human papillomavirus DNA testing in cervical cancer screening. J Natl Cancer Inst 101 (23): 1600-1601, 2009.
7. Pinto AP, Degen M, Villa LL and Cibas ES: Immunomarkers in gynecologic cytology: the search for the ideal 'biomolecular Papanicolaou test'. Acta Cytol 56 (2): 109-121, 2012.
8. Calin GA and Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66 (15): 7390-7394, 2006.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435 (7043): 834-838, 2005.
10. Liu A, Tetzlaff MT, Vanbelle P, Elder D, Feldman M, Tobias JW, Sepulveda AR and Xu X: MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol 2: 519-27, 2009.
11. Li J, Smyth P, Flavin R, Cahill S, Denning K Aherne S, Guenther SM, O'Leary JJ and Sheils O: Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7: 36, 2007.
12. Goswami RS, Waldron L, Machado J, Cervigne NK, Xu W, Reis PP, Bailey DJ, Jurisica I, Crump MR and Kamel-Reid S: Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples. BMC Biotechnol 10: 47, 2010.
13. Gocze K, Gombos K, Juhasz K, Kovacs K, Kajtar B, Benczik M, Gocze P, Patczai B, Arany I and Ember I: Unique microRNA expression profiles in cervical cancer. Anticancer Res 33 (6): 2561-2567, 2013.
14. Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer: OncomiRs and tumorsuppressor miRs in diagnosis and treatment. Scientific World Journal 2014: 178075, 2014.
15. Kaczkowski B, Morevati M, Rossing M, Cilius F and Norrild B: A Decade of Global mRNA and miRNA Profiling of HPVPositive Cell Lines and Clinical Specimens. Open Virol J 6: 216- 231, 2012.
16. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MA: MicroRNA expression variability in human cervical tissues. PLoS One 5 (7): e11780, 2010.
17. Gomez-Gomez Y, Organista-Nava J and Gariglio P: Deregulation of the miRNAs expression in cervical cancer: human papilloma virus implications. Biomed Res Int 2013: 407052, 2013.
18. Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, Tuschl T and Zheng ZM: microRNAs are biomarkers of oncogenic human papilloma virus infections. Proc Natl Acad Sci USA 111 (11): 4262-4267, 2014.
19. Galamb A, Pajor A, Langmar Z and Sobel G: Results of the first human papillomavirus center in Hungary (2007-2011). Orv Hetil 152 (45): 1804-1807, 2011.
20. Dickson EL, Vogel RI, Geller MA and Downs LS J: Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65. Gynecol Oncol 133 (3): 405-408, 2014.
21. Spinillo A, Dal Bello B, Gardella B, Roccio M, Dacco' MD and Silini EM: Multiple human papilloma virus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance of low grade squamous intraepithelial lesions. Gynecol Oncol 113 (1): 115-119, 2009.
22. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C and Zheng ZM: Aberrant expression of oncogenic and tumour-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3 (7): e2557, 2008.
23. Li B, Hu Y, Ye F, Li Y, Lv W and Xie X: Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papilloma virus infection. Int J Gynecol Cancer 20 (4): 597-604, 2010.
24. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM and De Flora S: Down-regulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23 (3): 806-812, 2009.
25. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Zhang X, Bowers J, Vaziri C, Ott K, Sensinger K, Collins JJ, Brody JS, Getts R, Lenburg ME and Spira A: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 106 (7): 2319-2324, 2009.
26. Russ R and Slack FJ: Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis. Pulm Med 2012: 791234, 2012.
27. Seddiki N, Brezar V, Ruffin N, Levy Y and Swaminathan S: Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology 142 (1): 32-38, 2014.
28. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82: 10436-10443, 2008.
29. Lao G, Liu P, Wu Q, Zhang W, Liu Y, Yang L and Ma C: Mir- 155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumour Biol 2014. 2014 Aug 26. [Epub ahead of print]
30. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pebusque MJ and Dusetti NJ: Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumour development. Proc Natl Acad Sci USA 104 (41): 16170-16175, 2007.
31. Ovcharenko D, Kelnar K, Johnson C, Leng N and Brown D: Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67 (22): 10782-10788, 2007.
32. Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y, Bao ZX and Jiang WW: MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential. Head Neck 2014. 2014 Apr 2. doi: 10.1002/hed.23700. [Epub ahead of print]
33. Chen D, Cabay RJ, Jin Y, WangA, Lu Y, Shah-Khan M and Zhou X: MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res 4 (1): e2, 2013.
34. Villegas-Ruiz V, Juarez-Mendez S, Perez-Gonzalez OA, Arreola H, Paniagua-Garcia L, Parra-Melquiadez M, Peralta-Rodriguez R, Lopez-Romero R, Monroy-GarciaA, Mantilla-Morales A, Gomez-Gutierrez G, Roman-Bassaure E and Salcedo M: Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol 7 (4): 1389- 1401, 2014.
35. Hou T, Ou J, Zhao X, Huang X, Huang Y and Zhang Y: MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer 110 (5): 1260-1268, 2014.
36. Severino P, Bruggemann H, Andreghetto FM, Camps C, Klingbeil M de F, de Pereira WO, Soares RM, Moyses R, Wunsch-Filho V, Mathor MB, Nunes FD, Ragoussis J and Tajara EH: MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. BMC Cancer 13: 533, 2013.
37. Wu H, Haag D, Muley T, Warth A, Zapatka M, Toedt G, Pscherer A, Hahn M, Rieker RJ, Wachter DL, Meister M, Schnabel P, Muller-Decker K, Rogers MA, Hoffmann H and Lichter P: Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma. Genes Chromosomes Cancer 52 (3): 250-264, 2013.
38. Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW and Lin SC: miR- 196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas. Ann Surg Oncol 20 (Suppl 3): S406-414, 2013.
39. Melar-New M and Laimins LA: Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins. J Virol 84 (10): 5212-5221, 2010.
40. Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y, Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumour growth and angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol Biochem 32 (1): 64-73, 2013.
41. Zhao S, Yao DS, Chen JY and Ding N: Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 14 (4): 2289-2293, 2013.